Literature DB >> 8527355

Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.

S Motomura1, K Hashimoto.   

Abstract

The influence of a new beta-blocker, celiprolol, on the direct dromotropic effects of the Ca antagonists, diltiazem and nifedipine, on atrioventricular (AV) conduction was estimated in the canine isolated, blood-perfused AV node preparation. Diltiazem (1-10 micrograms) and nifedipine (0.3-3 micrograms) injected i.a. into the AV node artery dose dependently prolonged the atrio-His (AH) interval (5-39 msec and 7-51 msec) in the AV mode preparation. When celiprolol (1 and 10 mg/kg) was given i.v. in the support dog, the AH interval in the AV node preparation was transiently shortened and then maintained constant as a control. These doses of i.v. celiprolol completely abolished the isoproterenol-induced decrease in the AH interval (28 msec at 0.03 microgram, i.a.) and AV nodal tachycardia. In the presence of celiprolol, the same doses of i.a. diltiazem and nifedipine increased the AH interval by the same amounts (6-43 msec and 8-53 msec) as the control. The incidence of second degree AV conduction block produced by diltiazem (2 in 5 AV node preparations at 10 micrograms) and nifedipine (2 in 6 preparations at 3 micrograms) was not changed by celiprolol. In the second experiments, diltiazem (30-300 micrograms/kg) and nifedipine (3-30 micrograms/kg), given i.v. in an open-chest in situ vagotomized dog, dose dependently increased AV conduction time (AVCT; 2-30 msec and 1-12 msec). Celiprolol 1 and 10 mg/kg i.v., which suppressed the isoproterenol-induced decrease in AVCT (32 msec at 0.3 mu/kg i.v.) and AV nodal tachycardia (4 in 6 in situ hearts), potentiated the prolongation of AVCT by the same doses of diltiazem (11-50 msec) and nifedipine (3-40 msec). The incidence of second degree AV conduction block produced by i.v., diltiazem (1 in 5 in situ hearts at 300 micrograms/kg) and nifedipine (0 in 6 in situ hearts at 30 micrograms/kg) was aggravated (4 in 5 and 3 in 6 in situ hearts) after i.v. celiprolol. These results indicate that although celiprolol does not affect the direct negative dromotropic effects of the Ca antagonists, AV block could easily be produced when celiprolol eliminates tonic adrenergic influences in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527355     DOI: 10.1007/bf00879034

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  29 in total

Review 1.  Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.

Authors:  W E Strauss; A F Parisi
Journal:  Ann Intern Med       Date:  1988-10-01       Impact factor: 25.391

2.  Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.

Authors:  B Silke; S P Verma; M A Frais; G Reynolds; S H Taylor
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

3.  Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.

Authors:  S H Taylor; B Silke; P S Lee; A Hilal
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

4.  The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.

Authors:  J Hung; I H Lamb; S J Connolly; K R Jutzy; M L Goris; J S Schroeder
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

5.  Effects of neurotransmitters injected into the posterior and the anterior septal artery on the automaticity of the atrioventricular junctional area of the dog heart.

Authors:  S Motomura; T Iijima; N Taira; K Hashimoto
Journal:  Circ Res       Date:  1975-08       Impact factor: 17.367

6.  Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.

Authors:  B Silke; S P Verma; S Guy
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

7.  Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.

Authors:  C Kawai; T Konishi; E Matsuyama; H Okazaki
Journal:  Circulation       Date:  1981-05       Impact factor: 29.690

Review 8.  Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.

Authors:  R M Brouwer; F Follath; F R Bühler
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

9.  Superiority of combined diltiazem and propranolol therapy for angina pectoris.

Authors:  W E Strauss; A F Parisi
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

10.  Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia.

Authors:  J J Rozanski; L Zaman; A Castellanos
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.